Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation
Renato D. Lópes(Duke University), Christopher B. Granger(Clinical Research Institute), Paul W. Armstrong(Canadian VIGOUR Centre), Kenneth W. Mahaffey(Cardiovascular Institute of the South), L. Kristin Newby(Duke University), E. Magnus Ohman(Tarzana Treatment Centers), Robert A. Harrington(Clinical Research Institute), Harvey D. White(University of Auckland), Lars Wallentin(Uppsala University), Rajendra H. Mehta(Manav Rachna International Institute of Research and Studies), Frans Van de Werf(KU Leuven), J.R. Horton(The University of Texas MD Anderson Cancer Center), Sana M. Al‐Khatib(American Heart Association), Karen S. Pieper(Clinical Research Institute)
Cited by 187
Related Papers
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2009|11.2k
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k